Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Retrovirus Life Cycles

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...

Diseases of the Liver and Gallbladder

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...

Hepatitis

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...

Viral Hepatitis I: Introduction

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...

Cirrhosis I: Introduction

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Multiple mechanisms, independent of sterol regulatory element binding proteins, regulate low density lipoprotein gene transcription.

Journal of lipid research·2000

Same author

Wilson's disease. Update of a systemic disorder with protean manifestations.

Gastroenterology clinics of North America·1999

Same author

Sterol-independent, sterol response element-dependent, regulation of low density lipoprotein receptor gene expression.

Journal of lipid research·1998

Same author

Overexpression of cholesterol 7alpha-hydroxylase (CYP7A) in mice lacking the low density lipoprotein (LDL) receptor gene. LDL transport and plasma LDL concentrations are reduced.

The Journal of biological chemistry·1998

Same author

Iron, HFE, and hemochromatosis update.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research·1998

Same author

Regulation of proliferation and Ras localization in transformed cells by products of mevalonate metabolism.

Cancer research·1997

Search research articles

Related Experiment Video

Updated: Jul 24, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

Hepatitis A: old and new.

¹Department of Internal Medicine, UT Southwestern Medical Center at Dallas, Dallas, Texas 75390-9151, USA. jennifer.cuthbert@utsouthwestern.edu

Clinical Microbiology Reviews

|January 9, 2001

Summary

Hepatitis A virus (HAV) causes widespread hepatitis through fecal contamination. Vaccination offers a promising path toward eradicating this common liver infection.

Area of Science:

Hepatology
Virology
Immunology

Background:

Hepatitis A virus (HAV) is a significant global cause of hepatitis.
Transmission occurs via person-to-person contact or contaminated food/water, particularly from endemic to non-endemic regions.
HAV infection leads to liver cell damage via cellular immune responses, causing disease symptoms.

Purpose of the Study:

To review the epidemiology, clinical manifestations, and management of Hepatitis A.
To highlight the role of immune responses in HAV pathogenesis and diagnosis.
To discuss the evolution and impact of immunoprophylaxis strategies for Hepatitis A.

Main Methods:

Literature review of HAV epidemiology, transmission routes, and clinical presentations.
Analysis of the roles of cellular and humoral immunity in Hepatitis A.

More Related Videos

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Published on: December 15, 2023

Related Experiment Videos

Last Updated: Jul 24, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Published on: December 15, 2023

Examination of historical and current immunoprophylaxis methods, including passive and active immunization.

Main Results:

HAV infection is endemic in developing countries, with decreasing exposure in developed nations due to improved sanitation.
Clinical outcomes range from asymptomatic infection in children to severe hepatic failure in adults.
Passive immunoprophylaxis (immune serum globulin) and active immunoprophylaxis (vaccination) are effective interventions.

Conclusions:

Hepatitis A management is primarily supportive, with most patients recovering fully.
Vaccination has made the future eradication of Hepatitis A a realistic possibility.
Understanding immune responses is crucial for diagnostic assays and therapeutic strategies.